Table of Contents
Chapter 1. Global Biosimilar Testing and Development Services Market Executive Summary
1.1. Global Biosimilar Testing and Development Services Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Biosimilar Testing and Development Services Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Biosimilar Testing and Development Services Market Dynamics
3.1. Market Drivers
3.1.1. Rising Demand for Biosimilars
3.1.2. Increasing Prevalence of Chronic Diseases
3.1.3. Expiration of Biologic Drug Patents
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements
3.2.2. Economic Impact of Recession
3.3. Market Opportunities
3.3.1. Growth in Outsourcing of Testing Services
3.3.2. Advancements in Testing Technologies
3.3.3. Expansion in Emerging Markets
Chapter 4. Global Biosimilar Testing and Development Services Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Biosimilar Testing and Development Services Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Biosimilar Testing and Development Services Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Pharmacokinetics Assay
5.2.2. Immunogenicity Testing
5.2.3. Others
Chapter 6. Global Biosimilar Testing and Development Services Market Size & Forecasts by End User 2022-2032
6.1. Segment Dashboard
6.2. Global Biosimilar Testing and Development Services Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Pharmaceutical and Biopharmaceutical Companies
6.2.2. Contract Research Organizations
6.2.3. Others
Chapter 7. Global Biosimilar Testing and Development Services Market Size & Forecasts by Region 2022-2032
7.1. North America Biosimilar Testing and Development Services Market
7.1.1. U.S. Biosimilar Testing and Development Services Market
7.1.1.1. Type breakdown size & forecasts, 2022-2032
7.1.1.2. End User breakdown size & forecasts, 2022-2032
7.1.2. Canada Biosimilar Testing and Development Services Market
7.2. Europe Biosimilar Testing and Development Services Market
7.2.1. UK Biosimilar Testing and Development Services Market
7.2.2. Germany Biosimilar Testing and Development Services Market
7.2.3. France Biosimilar Testing and Development Services Market
7.2.4. Spain Biosimilar Testing and Development Services Market
7.2.5. Italy Biosimilar Testing and Development Services Market
7.2.6. Rest of Europe Biosimilar Testing and Development Services Market
7.3. Asia-Pacific Biosimilar Testing and Development Services Market
7.3.1. China Biosimilar Testing and Development Services Market
7.3.2. India Biosimilar Testing and Development Services Market
7.3.3. Japan Biosimilar Testing and Development Services Market
7.3.4. Australia Biosimilar Testing and Development Services Market
7.3.5. South Korea Biosimilar Testing and Development Services Market
7.3.6. Rest of Asia Pacific Biosimilar Testing and Development Services Market
7.4. Latin America Biosimilar Testing and Development Services Market
7.4.1. Brazil Biosimilar Testing and Development Services Market
7.4.2. Mexico Biosimilar Testing and Development Services Market
7.4.3. Rest of Latin America Biosimilar Testing and Development Services Market
7.5. Middle East & Africa Biosimilar Testing and Development Services Market
7.5.1. Saudi Arabia Biosimilar Testing and Development Services Market
7.5.2. South Africa Biosimilar Testing and Development Services Market
7.5.3. Rest of Middle East & Africa Biosimilar Testing and Development Services Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Charles River Laboratories International, Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. SGS S.A.
8.3.3. Eurofins Scientific SE
8.3.4. Laboratory Corporation of America Holdings (LabCorp)
8.3.5. Pharmaceutical Product Development, LLC (PPD)
8.3.6. Intertek Group plc
8.3.7. Pace Analytical Services, LLC
8.3.8. Covance Inc.
8.3.9. ICON plc
8.3.10. Parexel International Corporation
8.3.11. WuXi AppTec
8.3.12. Syneos Health, Inc.
8.3.13. PPD, Inc.
8.3.14. BioOutsource Ltd. (a subsidiary of Sartorius AG)
8.3.15. Pharmalex GmbH
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes